Which of the following medications—carbamazepine, prednisone, atenolol, lorazepam, or amoxicillin—requires HLA‑B*1502 genetic testing due to the risk of severe cutaneous adverse reactions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Carbamazepine Requires HLA-B*1502 Genetic Testing

Carbamazepine is the medication that requires HLA-B*1502 genetic testing due to the risk of life-threatening Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). 1

Why Carbamazepine Specifically

  • The FDA recommends HLA-B*1502 screening before initiating carbamazepine in treatment-naïve patients, particularly those of Asian ancestry, to prevent severe cutaneous adverse reactions 1, 2
  • The association is extraordinarily strong: patients carrying HLA-B*1502 have an odds ratio of 113.4 (95% CI = 51.2-251.0) for developing carbamazepine-induced SJS/TEN 3
  • The drug is contraindicated in HLA-B*1502-positive patients who have never been exposed to carbamazepine 1

Population-Specific Risk

  • HLA-B*1502 is common in specific populations: 10-15% of Han Chinese, but <0.1% in Europeans 1
  • The allele is also prevalent in Oceanic, East Asian, and South/Central Asian populations (1-10%) 1
  • In Han Chinese populations from southern China mainland, 100% of SJS/TEN patients carried HLA-B*1502 versus only 13.75% of carbamazepine-tolerant controls 4

Clinical Effectiveness of Screening

  • The negative predictive value is 100% in Han Chinese populations, meaning a negative test effectively rules out this severe reaction 1
  • Number needed to screen: approximately 461 patients need HLA-B*1502 testing to prevent one episode of SJS/TEN 3
  • Screening programs have been successfully implemented in many Southeast Asian countries 1

Why the Other Medications Don't Require This Testing

  • Prednisone, atenolol, lorazepam, and amoxicillin have no HLA-B*1502 association and do not require genetic testing before use 1
  • While amoxicillin can rarely cause SJS, this is not HLA-mediated and has no genetic screening recommendation 1

Important Clinical Caveat

  • HLA-B*1502 screening is most critical in Asian populations; the association is weaker or absent in European populations 5
  • In Korean populations, HLA-B1511 and HLA-A3101 may be more relevant markers than HLA-B*1502 for carbamazepine-induced reactions 6
  • The test should be performed before the first dose in treatment-naïve patients; those already tolerating carbamazepine for >4 months are at lower risk 2

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the considerations for using carbamazepine in a patient of Chinese descent?
What gene predisposes to hypersensitivity and Stevens-Johnson syndrome (SJS) with allopurinol?
How should I evaluate and manage an otherwise healthy adolescent who presents with delayed puberty (age >13 years in girls or >14 years in boys)?
In a reproductive‑age woman with polycystic ovary syndrome who is not trying to conceive, how should spironolactone be started (initial dose and titration), what monitoring (serum potassium, renal function) and contraindications are required, and what alternative treatments are recommended?
Which of the following medications has a black‑box warning for tendon rupture: ciprofloxacin, azithromycin, doxycycline, amoxicillin, or cephalexin?
Which drug—phenytoin, warfarin, lisinopril, gabapentin, or lorazepam—exhibits time‑dependent zero‑order metabolism at high doses?
How is factor VII deficiency diagnosed and managed?
Which of levothyroxine, metoprolol, gabapentin, and spironolactone has the longest elimination half‑life?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question